摘要
目的探讨低分子肝素钙与小剂量尿激酶治疗进展性脑卒中的疗效。方法对医院收治的进展性脑卒中患者的临床资料进行分析汇总,依据治疗方式不同分为观察组(低分子肝素钙治疗组)30例和对照组(小剂量尿激酶治疗组)30例。结果观察组临床治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论低分子肝素钙治疗进展性脑卒中患者疗效明显,预后良好,值得临床借鉴应用。
Objective To approach the results of curative effect of curing progression of cerebral infarction by low molecular heparin calcium and low dose of urokinase.Methods To analyze clinical data of progression of cerebral infarction in our hospital,which was to be divided into detection group（low molecular heparin calcium and low dose of urokinase group）30 cases and control group（batroxobin group）30 cases.Results The clinical total effective rate of detection group was higher than control group,the difference was statistical significance（P0.05）.Conclusion The curing progression of cerebral infarction by low molecular heparin calcium and low dose of urokinase is obviously and eusemia,which is to be used.
出处
《中国医药科学》
2012年第22期46-47,共2页
China Medicine And Pharmacy
关键词
低分子肝素钙
小剂量尿激酶
进展性脑卒中
Low molecular heparin calcium
Low dose of urokinase
Progression of cerebral infarction
